P1644: NOVEL VARIANTS IN GALE CAUSED SYNDROMIC MACROTHROMBOCYTOPENIA DISRUPTING THROMBOPOIESIS AND GLYCOSYLATION

Autor: A. Marin Quilez, C. A. Di Buduo, L. Díaz-Ajenjo, P. M. Soprano, E. Vuelta, I. Serramito-Gómez, S. Santos-Mínguez, C. Miguel-García, S. Tocino-Antonio, V. Palma-Barqueros, A. Zamora-Canovas, P. Ruiz-Sala, M. J. Peñarrubia, E. Pardal, J. M. Hernández-Rivas, J. R. González-Porras, R. Benito, J. Rivera, I. García-Tuñón, A. Balduini, J. M. Bastida

Publikováno v: HemaSphere, Vol 6, Pp 1525-1526 (2022)

Externí odkaz: https://doaj.org/article/602d1874a1be4b73a2ca07ad017964f0

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment

Autor: C. Miguel García, Kamila Janusz, J.M. Hernández Sánchez, M. Martín Izquierdo, María Díez-Campelo, Fabio López, J.M. Hernández Rivas, C. Olivier, A. Hernández Sánchez, María Abáigar, Rocío Benito, S. Santos Mínguez, Marta Megido, Feliciano J. Ramos, José Martín Dávila, A. Madinaveitia-Ochoa, J. Sánchez del Real, M. Sierra, Mar Tormo, M.A. Vargas

Publikováno v: Leukemia Research. 108:106681.37

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::411802bdb6a1952a007666825dde1579
https://doi.org/10.1016/j.leukres.2021.106681.37

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia.

Autor: Quijada-Álamo M; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Pérez-Carretero C; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Hernández-Sánchez M; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA., Rodríguez-Vicente AE; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Herrero AB; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Hernández-Sánchez JM; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Martín-Izquierdo M; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Santos-Mínguez S; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Del Rey M; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., González T; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Rubio-Martínez A; Department of Hematology, Hospital Miguel Servet, Zaragoza, Spain., García de Coca A; Department of Hematology, Hospital Clínico de Valladolid, Valladolid, Spain., Dávila-Valls J; Department of Hematology, Hospital Nuestra Señora de Sonsoles, Ávila, Spain., Hernández-Rivas JÁ; Department of Hematology, Hospital Universitario Infanta Leonor, Universidad Complutense, Madrid, Spain., Parker H; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Strefford JC; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Benito R; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Ordóñez JL; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Hernández-Rivas JM; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.; Department of Medicine, University of Salamanca, Salamanca, Spain.

Publikováno v: Clinical and translational medicine [Clin Transl Med] 2021 Feb; Vol. 11 (2), pp. e304.